The treatment of pregnant women with a high number of hepatitis C virus needs to be analyzed in conjunction with the results of liver function and liver and gallbladder ultrasound; if the results are positive, antiviral hepatoprotective treatment is needed, and pregnancy can be terminated if necessary; on the contrary, it can be observed and life and dietary regimen until the end of the delivery of the integrated treatment.
At present, there is no good mother-to-child blockade after hepatitis C virus infection, antiviral treatment for hepatitis C may affect the fetus, and the latest treatment guidelines do not recommend treatment of HCV infection during pregnancy. The high hepatitis C virus in pregnant women needs to be taken into account in the selection of treatment measures.
First of all, liver function and hepatobiliary ultrasound should be checked first to see if there is any damage to liver function, and whether there is any significant elevation of indicators reflecting liver function, such as alanine aminotransferase, etc. When there is diffuse liver damage in hepatobiliary ultrasound examination, antiviral treatment should be done in time with pegylated interferon, and liver-protecting treatment should be done with biphenyldiltiazide and other drugs, and at the same time, consideration should be given to termination of pregnancy.
Simple hepatitis C with high viral load and no damage to liver function can be observed first, with attention to avoiding alcohol, eating less greasy food, monitoring liver function, and timely adjusting treatment measures according to the monitoring results.
HCV can be transmitted intrauterine during pregnancy and can also cause infection during delivery. However, most HCV-infected infants seem to be infected in the perinatal period (late pregnancy or at delivery), and it is recommended to seek timely consultation with an infectious disease and gynecology doctor to choose the appropriate treatment method.